ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals. 

Session date: 
Thursday, November 1, 2018 - 4:00pm to 5:00pm
Location: 
The Medical College of Wisconsin
8701 Watertown Plank Road
Health Research Center, 4th Floor, CVC Conference Room H4940
Milwaukee, WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Program Description: 

Endocrine Grand rounds is an educational conference in clinical and basic science in Endocrinology at The Medical College of Wisconsin campus on 1-2 Thursdays per month. The goal of this conference is for endocrinologists, endocrine surgeons, endocrine physician assistants, nurses, dietitians, endocrine fellows, nurse practitioners, PhD researchers, medicine residents and medical students to have a venue to present a variety of clinical and basic science updates as well as recent benchmarks in the field for the benefit of educating others and improve patient care on a vast array of topics in endocrinology.  The focus of this conference is education. 

This Endocrine Grand Rounds session is “supported by an unrestricted educational grant” from Ultragenyx.

Target audience: 

This activity is designed for endocrinology physicians, nurse practitioners, surgeons and referring physicians.

Learning objectives: 
  • Understand the role of the bone-derived hormone FGF23 in regulating blood phosphorus..
  • Be familiar with the skeletal disorders caused by excess circulating FGF23.
  • Have a better appreciation of the pathogenesis of X-linked hypophosphatemia as an example of FGF23-mediated disease and how that knowledge led to improved therapy for this disabling skeletal disease.
Faculty & credentials: 

Presenter:  Karl L. Insogna, MD

Activity Director: Denise Teves Qualler, MD

Planning Committee: Robert D Blank, MD, PhD

In accordance with the ACCME® standards for Commercial Support Number 6, all in control of contect disclosed any relevant financial relationships.

NameCompanyRole
Dr. Denise Teves QuallerAlexionTeacher
Dr. Robert BlankAmgen, Bristol Myers Squibb, Novo-Nordisk, Radius Health & UltragenyxConsultant
Dr. Robert BlankMcGraw Hill & UpToDateAuthor for Commissioned Educational Material
Dr, Karl InsognaUltragenyxPI for Clinical Trial
Dr. Karl InsognaUltragenyxScientific Advisory Board

These relationships were reviewed via the MCW conflict of interest resolution process and resolved.

CME Coordinator Contact Information

Name: 
Debra Warpechowski & Jess Rybold
Phone number: 
+1 (414) 955-6724